Peptide Vaccination for Patients at High Risk for Recurrent Melanoma
Clinical trial NCT00059475 · COMPLETED
Trial details
- NCT number
- NCT00059475
- Sponsor
- National Cancer Institute (NCI)
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2003-04-01
- Primary completion
- 2010-05-01
- Enrollment
- 138
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.